Dermatology Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

Dermatology Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

Dermatology Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

Dermatology Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

Dermatology Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis
Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

Expanding the Toolkit: Advances in Moderate to Severe Atopic Dermatitis Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

  • 0.5 credits

  • CNE, CME

Supported by an independent educational grant from Pfizer
Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

Expanding the Toolkit: Advances in Moderate to Severe Atopic Dermatitis Series

Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis

  • 0.5 credits

  • CNE, CME

Supported by an independent educational grant from Pfizer

About this course

General

Skill level: All levels
Estimated time to complete activity: 30 minutes
Release date: July 14, 2021
Expiration date: July 14, 2022

Languages

English

Accreditations

Continuing Nursing Education(CNE), Continuing Medical Education(CME)

Description

This program aims to specifically address gaps in recognition, treatment, and management of moderate to severe atopic dermatitis (MTSAD) for specialists focused on new and emerging therapies with special consideration and understanding of vaccinations involved with the care of AD patients.

Instructor

Peter Lio, MD

Contact Information

This activity is jointly provided by Medical Education Resources and LearnHealth Inc.

For questions regarding accreditation, please contact MER at 800-421-3756. For all other questions, please contact info@learnskin.com.

This activity is subject to MER's Privacy Policy and LearnSkin's Terms of Use.